| Serial Number | 85700753 |
| Word Mark | APHESIS |
| Filing Date | Friday, August 10, 2012 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, April 14, 2014 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 15, 2013 |
| Goods and Services | House mark for a full line of pharmaceuticals; pharmaceuticals for use in prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; pharmaceuticals for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; pharmaceuticals for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; preparations for detecting genetic predispositions for medical purposes |
| Goods and Services | Pharmaceutical and biotechnological research and development and product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, laboratory testing, diagnostics and pharmacogenetics; genetic mapping and testing for scientific purposes; scientific research in the field of genetics and genetic engineering; medical and scientific research, namely, conducting clinical trials and evaluations in the field of new pharmaceuticals; development of new technology for others in the fields of genomics and biotechnology; research and development of technologies for the prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; research and development of technologies for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; research and development of technologies for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the prevention and treatment of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 17, 2012 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 17, 2012 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Strategicon Partners, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Bellevue, WA 98007 |
| Party Name | Strategicon Partners, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Bellevue, WA 98007 |
| Event Date | Event Description |
| Monday, April 14, 2014 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, April 14, 2014 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, August 28, 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 26, 2013 | EXTENSION 1 GRANTED |
| Monday, August 26, 2013 | EXTENSION 1 FILED |
| Monday, August 26, 2013 | TEAS EXTENSION RECEIVED |
| Tuesday, March 12, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 15, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 15, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 26, 2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, December 7, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 7, 2012 | ASSIGNED TO EXAMINER |
| Friday, August 17, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, August 14, 2012 | NEW APPLICATION ENTERED IN TRAM |